Pfizer-BioNTech coronavirus vaccine receives full US FDA approval

The US Food and Drug Administration on Monday fully approved the Pfizer-BioNTech Covid vaccine, a move that triggered a new wave of vaccine mandates as the Delta variant batters the country.Around 52 per cent of the American population is fully vaccinated, but health authorities have hit a wall of vaccine-hesitant people, impeding the national campaign.“This is a pivotal moment for our country in the fight against the pandemic,” acting FDA Commissioner Janet Woodcock told reporters in a call…

Read the original article at South China Morning Post